ZimVie (NASDAQ:ZIMV) Issues Quarterly Earnings Results

ZimVie (NASDAQ:ZIMV) issued its earnings results on Wednesday. The company reported $0.08 earnings per share (EPS) for the quarter, Zacks reports. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%. The company had revenue of $118.20 million during the quarter. During the same quarter last year, the business earned $0.25 EPS. ZimVie updated its FY 2024 guidance to 0.550-0.700 EPS.

ZimVie Stock Performance

NASDAQ:ZIMV traded up $1.59 during midday trading on Thursday, reaching $16.97. The stock had a trading volume of 935,702 shares, compared to its average volume of 342,208. The company has a quick ratio of 2.32, a current ratio of 2.78 and a debt-to-equity ratio of 1.26. The stock has a market cap of $461.92 million, a P/E ratio of -1.04 and a beta of 2.17. ZimVie has a 12-month low of $6.52 and a 12-month high of $20.91. The firm has a fifty day simple moving average of $16.40 and a two-hundred day simple moving average of $15.00.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Barclays boosted their price objective on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research note on Tuesday, March 5th. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Thursday.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.